Antioxidant, Anti-Proliferative Activity and Chemical Fingerprinting of
CG-MS profiling
antioxidant potential
apoptosis
breast cancer
caspase-3
purple star thistle
Journal
Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981
Informations de publication
Date de publication:
03 Aug 2022
03 Aug 2022
Historique:
received:
02
06
2022
revised:
11
07
2022
accepted:
14
07
2022
entrez:
26
8
2022
pubmed:
27
8
2022
medline:
27
8
2022
Statut:
epublish
Résumé
Centaurea calcitrapa has been intensively utilized in ethnomedicinal practices as a natural therapeutic recipe to cure various ailments. The current study aimed to chemically characterize ethanolic extract of C. calcitrapa (EECC) aerial parts (leaves and shoots) by use of gas chromatography-mass spectrometry analyses (GC-MS) and investigate its antioxidant and in vitro anticancer activities, elucidating the underlying molecular mechanism by use of flow cytometry-based fluorescence-activated cell sorting (FACS) and conducting in silico assessment of binding inhibitory activities of EECC major compounds docked to caspase-3. CG-MS profiling of EECC identified a total of 26 major flavonoids and polyphenolic compounds. DPPH and ABTS assays revealed that EECC exhibits potent antioxidant activity comparable to standard reducing agents. Results of the proliferation assay revealed that EECC exhibit potent, dose-dependent cytotoxic activities against triple-positive (MCF-7) and triple-negative (MDA-MB-231) breast cancer cell models, with IC50 values of 1.3 × 102 and 8.7 × 101 µg/mL, respectively. The observed cytotoxic effect was specific to studied cancer cells since EECC exhibited minimal (~<10%) cytotoxicity against MCF-12, a normal breast cell line. FACS analysis employing annexin V-FITC/propidium iodide double labeling demonstrated that the observed anti-proliferative activity against MCF-7 and MDA-MB-231 was mediated via apoptotic as well as necrotic signaling transduction processes. The increase in fluorescence intensity associated with DCFH oxidation to DCF, as reported by FACS, indicated that apoptosis is caused by generation of ROS. The use of caspase-3-specific fluorogenic substrate revealed a dose-dependent elevation in caspase-3 substrate-cleavage activity, which further supports EECC-mediated apoptosis in MCF-7 cells. The major EECC compounds were examined for their inhibitory activity against caspase-3 receptor (1HD2) using molecular docking. Three compounds exhibited the highest glide score energy of −5.156, −4.691 and −4.551 kcal/mol, respectively. Phenol, 2,6-dimethoxy established strong binding in caspase-3 receptor of hydrogenic type, with residue ARG 207 and of PI-PI stacking type with residue HIS 121. By contract, hexadecenoic acid showed 3 H-bond with the following residues: ASN 615, ASN 616a and THR 646. Taken together, the current findings reveal that EECC exhibits significant and specific cytotoxicity against breast cancer cells mediated by the generation of ROS and culminating into necrosis and apoptosis. Further investigations of the phytoconstituents-rich C. calcitrapa are therefore warranted against breast as well as other human cancer cell models.
Identifiants
pubmed: 36009233
pii: antiox11081514
doi: 10.3390/antiox11081514
pmc: PMC9405406
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : King Saud University
ID : Vice Deanship of Research Chairs
Références
Oxid Med Cell Longev. 2021 Aug 5;2021:9965916
pubmed: 34394838
Mol Cell Biochem. 2016 May;416(1-2):141-55
pubmed: 27084536
Anticancer Agents Med Chem. 2020;20(8):1028-1036
pubmed: 32324522
Biomed Pharmacother. 2018 Mar;99:598-607
pubmed: 29710458
J Agric Food Chem. 2002 May 8;50(10):3010-4
pubmed: 11982434
Plants (Basel). 2019 Dec 24;9(1):
pubmed: 31878127
Turk J Pharm Sci. 2019 Sep;16(3):273-281
pubmed: 32454725
Mar Drugs. 2022 Jun 26;20(7):
pubmed: 35877710
Drug Chem Toxicol. 2021 Jul;44(4):427-436
pubmed: 31025581
Nat Prod Commun. 2016 Mar;11(3):275-8
pubmed: 27169173
Semin Cancer Biol. 2020 Feb;60:132-137
pubmed: 31002873
Eur J Med Chem. 2019 Sep 1;177:116-143
pubmed: 31129450
Trends Biochem Sci. 2011 Jan;36(1):30-8
pubmed: 20728362
Am J Pathol. 2013 Oct;183(4):1113-1124
pubmed: 23993780
Free Radic Biol Med. 2017 Mar;104:144-164
pubmed: 28088622
Biomed Pharmacother. 2016 Dec;84:1906-1914
pubmed: 27863838
J Food Biochem. 2021 Jan;45(1):e13579
pubmed: 33300136
Breast Cancer Res Treat. 2021 Jun;187(2):557-567
pubmed: 33515396
Mol Cell Biochem. 2014 Apr;389(1-2):85-98
pubmed: 24399465
Crit Rev Biotechnol. 2004;24(2-3):59-83
pubmed: 15493526
Nat Prod Res. 2019 Jun;33(11):1687-1690
pubmed: 29457735
Biochem J. 2012 Jan 15;441(2):523-40
pubmed: 22187934
Aging (Albany NY). 2021 Feb 11;13(4):5748-5803
pubmed: 33592581
Plants (Basel). 2020 Sep 30;9(10):
pubmed: 33008079
Curr Med Chem. 2010;17(2):129-38
pubmed: 19941474
AMB Express. 2020 Oct 12;10(1):183
pubmed: 33044582
Oncol Lett. 2016 Jan;11(1):642-648
pubmed: 26870259
Mol Biol Rep. 2020 Aug;47(8):6043-6051
pubmed: 32700127
Nanomaterials (Basel). 2020 Aug 26;10(9):
pubmed: 32859033
Biotech Histochem. 2021 Jan;96(1):1-10
pubmed: 32362148
Lancet. 2017 Mar 18;389(10074):1134-1150
pubmed: 27865536
Int J Oncol. 2016 May;48(5):1886-94
pubmed: 26983896